Surgalign Holdings Performance
| SRGADelisted Stock | USD 0.04 0 12.54% |
The entity has a beta of 2.24, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Surgalign Holdings will likely underperform. Surgalign Holdings right now has a risk of 0.0%. Please validate Surgalign Holdings skewness and the relationship between the daily balance of power and period momentum indicator , to decide if Surgalign Holdings will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Surgalign Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Surgalign Holdings is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 51.3 M |
Surgalign |
Surgalign Holdings Relative Risk vs. Return Landscape
If you would invest 3.50 in Surgalign Holdings on August 17, 2024 and sell it today you would earn a total of 0.00 from holding Surgalign Holdings or generate 0.0% return on investment over 90 days. Surgalign Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Surgalign, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgalign Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgalign Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgalign Holdings, and traders can use it to determine the average amount a Surgalign Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SRGA |
Based on monthly moving average Surgalign Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgalign Holdings by adding Surgalign Holdings to a well-diversified portfolio.
Surgalign Holdings Fundamentals Growth
Surgalign Stock prices reflect investors' perceptions of the future prospects and financial health of Surgalign Holdings, and Surgalign Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgalign Stock performance.
| Return On Equity | -14.97 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | (7.93 M) | |||
| Shares Outstanding | 9.18 M | |||
| Price To Book | 1.79 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 81.98 M | |||
| EBITDA | (68.28 M) | |||
| Cash And Equivalents | 29.34 M | |||
| Cash Per Share | 4.35 X | |||
| Total Debt | 10.19 M | |||
| Debt To Equity | 0.54 % | |||
| Book Value Per Share | (2.08) X | |||
| Cash Flow From Operations | (52.11 M) | |||
| Earnings Per Share | (8.12) X | |||
| Total Asset | 70.24 M | |||
| Retained Earnings | (624.22 M) | |||
About Surgalign Holdings Performance
By analyzing Surgalign Holdings' fundamental ratios, stakeholders can gain valuable insights into Surgalign Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgalign Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgalign Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.Things to note about Surgalign Holdings performance evaluation
Checking the ongoing alerts about Surgalign Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgalign Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgalign Holdings is not yet fully synchronised with the market data | |
| Surgalign Holdings has some characteristics of a very speculative penny stock | |
| Surgalign Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 81.98 M. Net Loss for the year was (54.6 M) with profit before overhead, payroll, taxes, and interest of 40.29 M. | |
| Surgalign Holdings currently holds about 29.34 M in cash with (52.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Surgalign Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgalign Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Surgalign Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgalign Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgalign Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgalign Holdings' stock. These opinions can provide insight into Surgalign Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |